previous compound ID: 979 next compound
InChIKey: IPEHBUMCGVEMRF-UHFFFAOYSA-N
SMILES: C1=CN=C(C=N1)C(=O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "J Liao" "E Matthes" "R Robert" "GW Carlile" "B Kus" "J Goepp" "SD Macknight" "D Rotin" "DY Thomas"

chemical graph of compound 979





CID is 1046
synonyms found at PubChem are:
pyrazinamide, pyrazinecarboxamide, pyrazine-2-carboxamide, 98-96-4, Zinamide, pyrazinoic acid amide, 2-Pyrazinecarboxamide, Aldinamide, Aldinamid, Pirazinamid, Pyrazineamide, Pyrafat, Tebrazid, Unipyranamide, Farmizina, Pirazimida, pyrazine carboxylamide, Eprazin, Novamid, 2-Carbamylpyrazine, Pyrazinecarboxylic acid amide, Pyrazinamidum, Pirazinamida, Tisamid, Isopas, Pirazinamide, Pyrazine carboxamide, Pezetamid, Piraldina, Braccopiral, Corsazinmid, Pyrazinamdie, Dipimide, Lynamide, Prazina, Pyramide, Pyrazide, Tebrazio, Zinastat, Rozide, Pirazinamide [DCIT], MK 56, PZA, D-50, Pyrazinamidum [INN-Latin], NCI-C01785, Pirazinamida [INN-Spanish], C5H5N3O, Pharozinamide, Pyrazinamid, P ezetamid, pms-Pyrazinamide, D-50 (VAN), UNII-2KNI5N06TI, DRG 0124, NSC 14911, CCRIS 545, Pyrazinamide (TN), 2-carbamyl pyrazine, Pyrazinamide [INN:BAN:JAN], HSDB 3576, Pyrazinoic acid am ide, T 165, Pyrazinamide BP 2000, EINECS 202-717-6, BRN 0112306, 2KNI5N06TI, MLS000069730, AZT + Pyrazinamide combination, CHEBI:45285, Pyrazine-2-carboxylic acid amide, IPEHBUMCGVEMRF-UHFFFAOYSA-N, NSC14911, Pyrazinamide (Pyrazinoic acid amide), NCGC00015833-09, SMR000036662, DSSTox_CID_1215, P 7136, DSSTox_RID_76014, DSSTox_GSID_21215, Rifafour, CAS-98-96-4, Rifafour e-200, SR-01000076077, pyramizade, pyrazinamida, Pyrizinamide, pyrazine amide, alpha-pyrazinamide, Pyrazinamide,(S), Pyrazinamide [USP:INN:BAN:JAN], 2-Carbamoylpyrazine, Prestwick_811, ACMC-20aive, 2-pyrazine carboxamide, Spectrum_000902, Opera_ID_735, AC1L1ALT, AC1Q4ZGM, Prestwick0_000514, Prestwick1_000514, Prestwick2_000514, Prestwick3_000514, Spectrum2_001305, Spectrum3_001046, Spectrum4_001186, Spectrum5_001026, Lopac-P-7136, CHEMBL614, D0XF8W, WLN: T6N DNJ BVZ, pyrazine-2-carboximidic acid, Lopac0_001011, SCHEMBL24102, BSPBio_000467, BSPBio_002572, KBioGR_001851, KBioSS_001382, 5-25-04-00178 (Beilstein Handbook Reference), KSC449E8F, MLS002222347, BIDD:GT0228, DivK1c_000241, SPECTRUM1500518, SPBio_001369, SPBio_002388, BPBio1_000515, EBD430, GTPL7287, ZINC2005, DTXSID9021215, 2-pyrazinecarboxylic acid amide;, HMS500M03, KBio1_000241, KBio2_001382, KBio2_003950, KBio2_006518, KBio3_001792, Pyrazinamide (JP15/USP/INN), Pyrazinamide (JP17/USP/INN), MolPort-001-770-770, MolPort-023-219-632, NINDS_000241, BDBM228814, HMS1569H09, HMS1920N08, HMS2092E09, HMS2096H09, HMS2235G17, HMS3259O04, HMS3263K03, HMS3371G09, HMS3655A10, HMS3713H09, KUC109577N, Pharmakon1600-01500518, ACT01761, HY-B0271, KS-00000B7D, KSC-27-052E, Tox21_110237, Tox21_202059, Tox21_302771, Tox21_501011, ANW-75384, BBL010592, CCG-39243, MFCD00006132, NSC-14911, NSC757304, s1762, SBB004276, STK801661, AKOS000120280, Tox21_110237_1, CS-2260, DB00339, LP01011, LS-2053, MCULE-6846697749, NC00534, NSC-757304, Pyrazinecarboxamide, analytical standard, IDI1_000241, NCGC00015833-01, NCGC00015833-02, NCGC00015833-03, NCGC00015833-04, NCGC00015833-05, NCGC00015833-06, NCGC00015833-07, NCGC00015833-08, NCGC00015833-10, NCGC00015833-11, NCGC00015833-12, NCGC00015833-15, NCGC00015833-16, NCGC00090695-01, NCGC00090695-03, NCGC00090695-04, NCGC00090695-05, NCGC00090695-06, NCGC00090695-07, NCGC00256336-01, NCGC00259608-01, NCGC00261696-01, Pyrazinoic acid amide; pyrazinamide; PZA, AJ-08121, CAS- 98-96-4, CPD000036662, SAM002554927, SC-46323, TS-01626, SBI-0050984.P004, AB0008224, AB2000278, AJ-138256, DB-002866, KB-204556, ST2413707, TR-030381, AB00052083, B2122, BB 0253141, EU-0101011, FT-0659757, P0633, ST45022155, C01956, D00144, J10111, M-7421, AB00052083-16, AB00052083_17, AB00052083_18, AC-907/25014068, I14-6758, SR-01000076077-1, SR-01000076077-4, SR-01000076077-6, W-100059, Z33546644, Pyrazinamide, British Pharmacopoeia (BP) Reference Standard, Pyrazinamide, European Pharmacopoeia (EP) Reference Standard, Pezetamid;Pyrafat;Zinamide;Tebrazid;Pyrafat;Pyrazinoic acid amide, Pyrazinamide, United States Pharmacopeia (USP) Reference Standard, InChI=1/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9, Pyrazinamide, Pharmaceutical Secondary Standard; Certified Reference Material, Pyrazinoic acid amide, Pezetamid, Pyrafat, Zinamide, Tebrazid, Pyrafat, Pyrazinamide